Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    17082464 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Safety, Tolerability and Efficacy Assessment of Dynacirc CR in Parkinson Disease
Condition: Parkinson Disease
Interventions: Drug: Isradipine CR 5mg;   Drug: Isradipine CR 10mg;   Drug: Isradipine CR 20mg;   Drug: Placebo
2 Completed A Multifactorial Exercise Program to Reduce Falls in People With Parkinson Disease
Condition: Parkinson Disease
Intervention: Behavioral: Balance & Strengthening Exercises
3 Recruiting Remote Access to Care, Everywhere, for Parkinson Disease
Condition: Parkinson Disease
Intervention: Other: Virtual care visit

Indicates status has not been verified in more than two years